Adstiladrin Interactions
There are 303 drugs known to interact with Adstiladrin (nadofaragene firadenovec), along with 1 disease interaction. Of the total drug interactions, 292 are major, and 11 are moderate.
- View Adstiladrin disease interactions (1)
Medications known to interact with Adstiladrin
Note: Showing generic names only.
A
- abatacept
- abemaciclib
- abrocitinib
- acalabrutinib
- adalimumab
- afamitresgene autoleucel
- aldesleukin
- alefacept
- alemtuzumab
- allogeneic processed thymus tissue
- altretamine
- anakinra
- anifrolumab
- anti-thymocyte globulin (rabbit)
- asciminib
- asparaginase escherichia coli
- atezolizumab
- avacopan
- avapritinib
- avelumab
- axicabtagene ciloleucel
- azacitidine
- azathioprine
B
- baricitinib
- basiliximab
- beclomethasone
- beclomethasone nasal
- belantamab mafodotin
- belatacept
- belimumab
- belinostat
- bendamustine
- betamethasone
- betamethasone topical
- bexarotene
- bimekizumab
- bleomycin
- blinatumomab
- bortezomib
- bosutinib
- brentuximab
- brexucabtagene autoleucel
- brigatinib
- brodalumab
- budesonide
- budesonide nasal
- busulfan
C
- cabazitaxel
- canakinumab
- capecitabine
- carboplatin
- carfilzomib
- carmustine
- cemiplimab
- certolizumab
- chlorambucil
- ciclesonide
- ciclesonide nasal
- ciltacabtagene autoleucel
- cisplatin
- cladribine
- clobetasol topical
- clofarabine
- cobimetinib
- copanlisib
- corticotropin
- cortisone
- crovalimab
- cyclophosphamide
- cyclosporine
- cytarabine
- cytarabine liposomal
D
- dacarbazine
- daclizumab
- dactinomycin
- danicopan
- daratumumab
- dasatinib
- daunorubicin
- daunorubicin liposomal
- decitabine
- deflazacort
- denileukin diftitox
- deucravacitinib
- dexamethasone
- dexamethasone nasal
- dexamethasone topical
- dexrazoxane
- dimethyl fumarate
- dinutuximab
- diroximel fumarate
- docetaxel
- dostarlimab
- doxorubicin
- doxorubicin liposomal
- dupilumab
- durvalumab
- duvelisib
E
- eculizumab
- efalizumab
- efgartigimod alfa
- eflornithine
- elivaldogene autotemcel
- elotuzumab
- elranatamab
- emapalumab
- enfortumab vedotin
- epcoritamab
- epirubicin
- eribulin
- etanercept
- etoposide
- etrasimod
- everolimus
F
- fam-trastuzumab deruxtecan
- fexinidazole
- fingolimod
- floxuridine
- fludarabine
- fludrocortisone
- flunisolide
- flunisolide nasal
- fluorouracil
- fluticasone
- fluticasone nasal
- fluticasone topical
- fruquintinib
G
H
I
- ibritumomab
- ibrutinib
- idarubicin
- idecabtagene vicleucel
- idelalisib
- ifosfamide
- imatinib
- imetelstat
- inavolisib
- inebilizumab
- infliximab
- inotuzumab ozogamicin
- iobenguane I 131
- iodine i 131 tositumomab
- ipilimumab
- iptacopan
- irinotecan
- irinotecan liposomal
- isatuximab
- ixabepilone
- ixazomib
- ixekizumab
L
- lebrikizumab
- leflunomide
- lenalidomide
- levamisole
- lifileucel
- lisocabtagene maraleucel
- lomustine
- loncastuximab tesirine
- lurbinectedin
- lutetium lu 177 dotatate
- lutetium lu 177 vipivotide tetraxetan
- lymphocyte immune globulin, anti-thy (equine)
M
- mechlorethamine
- melphalan
- melphalan flufenamide
- mercaptopurine
- methotrexate
- methylprednisolone
- methylprednisolone topical
- midostaurin
- mirikizumab
- mitomycin
- mitoxantrone
- mogamulizumab
- momelotinib
- mometasone
- mometasone nasal
- mometasone topical
- monomethyl fumarate
- mosunetuzumab
- muromonab-cd3
- mycophenolate mofetil
- mycophenolic acid
N
O
- obinutuzumab
- ocrelizumab
- ofatumumab
- olaparib
- olaratumab
- omacetaxine
- osimertinib
- oxaliplatin
- ozanimod
P
- paclitaxel
- paclitaxel protein-bound
- pacritinib
- palbociclib
- panobinostat
- pazopanib
- pegaspargase
- pegcetacoplan
- pembrolizumab
- pemetrexed
- pentostatin
- pirtobrutinib
- plicamycin
- polatuzumab vedotin
- pomalidomide
- ponatinib
- ponesimod
- pozelimab
- pralatrexate
- prednisolone
- prednisone
- procarbazine
R
- ravulizumab
- retifanlimab
- revumenib
- ribociclib
- rilonacept
- risankizumab
- ritlecitinib
- rituximab
- romidepsin
- ropeginterferon alfa-2b
- rozanolixizumab
- rucaparib
- ruxolitinib
S
- sacituzumab govitecan
- sarilumab
- satralizumab
- secukinumab
- selinexor
- siltuximab
- siponimod
- sirolimus
- sirolimus protein-bound
- sirolimus topical
- spesolimab
- streptozocin
- sutimlimab
T
- tacrolimus
- tafasitamab
- talazoparib
- talquetamab
- tarlatamab
- tazemetostat
- teclistamab
- temozolomide
- temsirolimus
- teniposide
- teplizumab
- teriflunomide
- thalidomide
- thioguanine
- thiotepa
- tildrakizumab
- tisagenlecleucel
- tisotumab vedotin
- tocilizumab
- tofacitinib
- topotecan
- toripalimab
- tositumomab
- trabectedin
- tralokinumab
- trastuzumab
- tremelimumab
- triamcinolone
- triamcinolone nasal
- triamcinolone ophthalmic
- triamcinolone topical
- trimetrexate
U
V
- vamorolone
- vedolizumab
- venetoclax
- vilobelimab
- vinblastine
- vincristine
- vincristine liposome
- vinorelbine
- voclosporin
Z
Adstiladrin disease interactions
There is 1 disease interaction with Adstiladrin (nadofaragene firadenovec) which include:
More about Adstiladrin (nadofaragene firadenovec)
- Adstiladrin consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.